"Designing Growth Strategies is in our DNA"

U.S. Tuberculosis (TB) Diagnostics Market Size, Share & Industry Analysis, By Type (Interferon Gamma Release Assay (IGRA), Tuberculin Skin Test (TST), Nucleic Acid Amplification Test (NAAT), Culture-based Diagnostics, Sputum Smear Microscopy, and Others), By End-user (Diagnostic Laboratories, Hospitals and Clinics, and Others), and Country Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI109193

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology: Tuberculosis, U.S., 2024
    2. Technological Advancements: Tuberculosis Diagnostics
    3. New Product Launches
    4. Key Industry Developments – (Mergers, Acquisitions & Partnerships, etc.)
  5. U.S. Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Interferon Gamma Release Assay (IGRA)
      2. Tuberculin Skin Test (TST)
      3. Nucleic Acid Amplification Test (NAAT)
      4. Culture-based Diagnostics
      5. Sputum Smear Microscopy
      6. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories
      2. Hospitals and Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2024)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Revvity
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. QIAGEN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Cepheid (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Hologic Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Quest Diagnostics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. IntelliGenome
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology: Tuberculosis, U.S., 2024
    2. Technological Advancements: Tuberculosis Diagnostics
    3. New Product Launches
    4. Key Industry Developments – (Mergers, Acquisitions & Partnerships, etc.)
  5. U.S. Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Interferon Gamma Release Assay (IGRA)
      2. Tuberculin Skin Test (TST)
      3. Nucleic Acid Amplification Test (NAAT)
      4. Culture-based Diagnostics
      5. Sputum Smear Microscopy
      6. Others
    2. Market Analysis, Insights and Forecast – By End-user
      1. Diagnostic Laboratories
      2. Hospitals and Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2024)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Revvity
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. QIAGEN
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. BD
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Cepheid (Danaher)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Hologic Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Quest Diagnostics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. IntelliGenome
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: U.S. Tuberculosis (TB) Diagnostics Market Revenue Breakdown (USD million, %) by Type, 2024 & 2032

Figure 2: U.S. Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2024 & 2032

Figure 3: U.S. Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2024 & 2032

Figure 4: U.S. Tuberculosis (TB) Diagnostics Market Share (%), 2024

Table 1: U.S. Tuberculosis (TB) Diagnostics Market Revenue (USD million) Forecast, by Type, 2019–2032

Table 2: U.S. Tuberculosis (TB) Diagnostics Market Revenue (USD million) Forecast, by End-user, 2019–2032

U.S. Tuberculosis (TB) Diagnostics Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 78
  • Buy Now

    (Offer valid till 15th Dec 2025)

Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports